Lundin Mining Announces Updated Share Capital, Provides Update on Share Buybacks and Announces Filing of ESTMA Report and Modern Slavery Report
The number of issued and outstanding shares of the Company has increased by 179,029 to 855,997,663 common shares with voting rights as of June 30, 2025. The increase in the number of issued and outstanding shares from May 31, 2025 to date is a result of the exercise of employee stock options or the vesting of employee share units. During this period, the Company did not purchase any shares for cancelation under its Normal Course Issuer Bid program.
Normal Course Issuer Bid
Under the Company's shareholder distribution policy, the Company is committed to allocating up to US$150 million in annual share buybacks through the NCIB program. So far during 2025, Lundin Mining has acquired 12,629,000 common shares at a cost of approximately US$104 million.
Lundin Mining has filed its ESTMA Report and Modern Slavery Report for the year ended December 31, 2024, which can be found on the Company's website (lundinmining.com).
About Lundin Mining
Lundin Mining is a diversified base metals mining company with operations or projects in Argentina, Brazil, Chile, and the United States of America, primarily producing copper, gold and nickel.
The information in this release is subject to the disclosure requirements of Lundin Mining under the Swedish Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact persons set out below on June 30, 2025 at 16:00 Pacific Time.
SOURCE Lundin Mining Corporation
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
2 hours ago
- Globe and Mail
1 Stock Down 40% This Year to Buy and Hold
Key Points Novo Nordisk's shares have been trending downward due to clinical setbacks and underwhelming results. However, the company has some potential catalysts on the way that could jolt its stock price. Novo Nordisk looks attractive given its lineup and pipeline, especially at current levels. 10 stocks we like better than Novo Nordisk › Novo Nordisk (NYSE: NVO) first earned U.S. approval for its now-famous weight management medicine Wegovy in June 2021. That marked the beginning of a strong run for the company on the stock market. However, the Denmark-based drugmaker has given up most of these gains over the past year; the stock is down by 40% since January alone. Despite its recent misfortunes, Novo Nordisk's shares could still deliver strong returns to patient investors. Here's why. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » NVO Total Return Level data by YCharts. The weight management opportunity Novo Nordisk primarily develops medicines for diabetes and, in recent years, weight management. Its stock has plunged over the past year because its financial results haven't been as impressive as the market had hoped. It also faced some clinical setbacks, while its biggest rival in its core markets, Eli Lilly, earned some important wins. However, there's more to the story. The market for anti-obesity medications could grow at an incredibly rapid rate. Some analysts estimate that it will be worth $150 billion by 2035, compared to $15 billion last year. Novo Nordisk still has one of the deepest pipelines in the industry. In fact, it's challenging to find a company other than Eli Lilly that has more promising products. Recently, Novo Nordisk expanded its pipeline through various licensing deals. Here's one more thing that recently broke its way: Eli Lilly's oral GLP-1 candidate, orforglipron, did not perform nearly as well as expected in a phase 3 study. This opens the door for Novo Nordisk to catch up to its longtime rival. The company's oral version of Wegovy is currently awaiting approval from regulators in the U.S. The oral version led to an average weight reduction of 13.6% in a phase 3 clinical trial, slightly higher than the 12.4% that orforglipron recently posted in its late-stage study. While it's always hard to compare across clinical trials, the data at the very least suggests that oral Wegovy is comparable to orforglipron -- but only the former drug is closing in on approval. Novo Nordisk also has yet another promising anti-obesity candidate in phase 3 studies, amycretin, which the Denmark-based pharmaceutical giant is testing in both subcutaneous and oral formulations. Why is the race to develop an oral weight loss option so important? Pills are easier and cheaper to manufacture, store, and transport. So, compared to injectable weight loss therapies, oral versions would allow drugmakers to produce them more cost-effectively and to expand the reach of weight loss therapies. On top of that, some patients are strongly averse to needles. Because the current leading weight management drugs are administered subcutaneously, an oral option would likely take a decent share of the market. Novo Nordisk is likely to be first to market. And the company could follow up that win with another oral product in amycretin. The price is right Let's go back to Novo Nordisk's recent and disappointing financial results. In the first half of the year, revenue rose by 16% year over year to 154.9 billion Danish kroner ($24.2 billion), while net profit came in at 55.5 billion DKK ($8.7 billion). Perhaps that's not quite what the market expected to see, but these are still excellent results for a pharmaceutical giant -- most drugmakers of that size would be happy to grow their revenue at high-single-digit or low-double-digit rates. Meanwhile, the stock appears reasonably valued, trading at 13 times forward earnings, compared to the healthcare industry 's average of 16.2. What's the verdict? Novo Nordisk looks attractive at current levels, given the company's strong pipeline in weight management and a lineup that continues to deliver consistent profits. Despite recent setbacks, the stock is well-positioned to deliver excellent results over the long term. Should you invest $1,000 in Novo Nordisk right now? Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Novo Nordisk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,155!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,106,071!* Now, it's worth noting Stock Advisor's total average return is 1,070% — a market-crushing outperformance compared to 184% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025
CTV News
4 hours ago
- CTV News
Duty-free shops facing ‘full-blown crisis' with no relief in sight
John Slipp is seen at his closed duty-free store, at the Canada-U.S. border crossing between Woodstock, N.B., and Houlton, Maine, on Thursday, Aug. 14, 2025. THE CANADIAN PRESS/Stephen MacGillivray John Slipp took over his father's duty-free store in 1994, which had been started more than a decade earlier. This month, he closed the Woodstock Duty Free Shop Inc. as lower traffic at the U.S.-Canada border dealt the final blow to a business already weakened by the COVID-19 pandemic. Now, at 59, Slipp says he will have to find another source of income and is advocating for more government support for stores like his. Fewer Canadians have been heading south in recent months in response to U.S. President Donald Trump's trade war with Canada, his comments about annexing the country and because of fears among travellers about treatment at the border. In the duty-free industry, Slipp said less border traffic directly correlates to fewer sales. 'It was very difficult. The business had many good years. I certainly didn't want to be in the position of calling an end to a business career, giving up, calling it quits, both personally and in terms of my late father,' Slipp said. At the store's peak in the early 2000s, Slipp said there were about 15 people on staff. In March 2020, he said he laid off four people and reopened after the pandemic with two employees. Late in the summer of 2021, Slipp said duty-free stores were 'all starting from zero to rebuild again.' By the end of 2024, his business was still down about one-fifth from where it was in 2019. Then Trump returned to the White House. From January to April this year, things got worse for Slipp's store, and he ultimately decided to close based on declining sales and traffic numbers. 'Just realizing that even after the U.S. administration changes down the road, in our industry, we do not expect the border traffic to change overnight as a result of that. We believe it's going to take years,' he said. Recent figures from Statistics Canada noted that return trips from the U.S. dropped again in July as Canadians continue to shun travel to the U.S. The number of Canadian residents returning from the U.S. by automobile was down 36.9 per cent on an annual basis in July, marking the seventh consecutive month of year-over-year declines. Barbara Barrett, executive director of the Frontier Duty Free Association, said the stores her association represents have been feeling the decline in traffic for months. 'I would describe our industry as being in a full-blown crisis, and we've been saying that for a number of months now,' she said. Sales at duty-free stores have fallen between 40 and 50 per cent year-over-year across the country since late January, with some remote crossings reporting annual declines of up to 80 per cent, the association said. Barrett added that duty-free stores are often a microcosm of what is happening at the border. 'This should be our busy season during the summer, but it is not; it is pandemic-level traffic in the parking lots, and it has led to one store closing in the east. We are unfortunately afraid that we will likely see more closures as we draw to the end of the summer,' she said. Unlike airport stores, which are often owned by international companies, Barrett noted all of the land border stores are independently owned and are often family-run businesses. While Canadians shun U.S. trips, travel expert Claire Newell said many are opting for domestic and other international destinations. 'We live in a country where it's still very expensive to travel domestically. And while there are many people who are choosing to travel within Canada, we also see more people heading to popular destinations,' she said. She said she doesn't see Canadians changing their travel habits back to normal until there is a trade deal 'that feels fair.' As lower border traffic weighs on the industry, Barrett said she is advocating for 'small regulatory changes.' 'We have some taxes on our products that, believe it or not, in a tax- and duty-free industry that our U.S. competitors don't have. So we're asking for those to be changed so we can be more competitive,' she said. 'Also, we're asking to qualify for some of these tariff relief programs or pandemic-level supports along the lines of what they did during the pandemic with wage subsidy or rent subsidy.' Barrett said the government is the landlord for many duty-free stores and said a rent deferral or subsidy would help the industry until travel patterns normalize. She added that there have been conversations between her organization and senior government officials. Barrett said those officials agreed the association was putting forward 'small asks' to support the industry. An Aug. 2 release announcing the Woodstock Duty Free Shop's closure mentioned that the federal and provincial governments had promised tariff relief support programs to help businesses impacted by trade tensions. 'I pinned a lot of hopes on those when both levels of government made those announcements. I was reminded of the pandemic support programs,' Slipp said, adding that his business had benefited from such programs. His attention has now turned to advocating for rent deferral programs for duty-free shops renting land from either the federal government or from a bridge authority as well as loan programs for duty-free stores. When he looks at the future of the industry, he said the prospects 'are not bright.' 'I'm grieving the loss of my business, but I'm also accepting the reality that the business environment has changed and there is nothing in the bag of tricks that would suggest positive changes in this industry in the short to medium term,' Slipp said. 'I'm feeling bad that I was not able to succeed in the end and that I am having to lay to rest this business that my father and I have built and spent so many years working so hard on.' This report by The Canadian Press was first published Aug. 17, 2025. Daniel Johnson, The Canadian Press
CTV News
a day ago
- CTV News
Housing woes & U.S. relationship fears top Canadian concerns
Watch Nik Nanos unpacks home prices, affordability, and why Trump and U.S. ties are now Canada's leading worry.
